Cover
| Cover | May 22, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Document Period End Date | May 22, 2024 |
| Entity Registrant Name | Privia Health Group, Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-40365 |
| Entity Tax Identification Number | 81-3599420 |
| Entity Address, Address Line One | 950 N. Glebe Rd., |
| Entity Address, Address Line Two | Suite 700 |
| Entity Address, State or Province | VA |
| Entity Address, City or Town | Arlington, |
| Entity Address, Postal Zip Code | 22203 |
| City Area Code | 571 |
| Local Phone Number | 366-8850 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.01 par value per share |
| Trading Symbol | PRVA |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Entity Central Index Key | 0001759655 |
| Amendment Flag | true |
| Amendment Description | On May 22, 2024, Privia Health Group, Inc. (the “Company”) filed a Current Report on Form 8-K with the Securities and Exchange Commission (the “SEC”) disclosing, among other things, the results of its 2024 annual meeting of shareholders (the “Original Report”) held on May 22, 2024 (the “Annual Meeting”). This Current Report on Form 8-K/A amends and restates Item 5.07 of the Original Report to correct the voting results reported for Proposal No. 2, for which the number of Votes Against was inadvertently overstated in the Original Report.As required by Rule 12b-15 under the Securities Exchange Act of 1934, the Company has set forth the complete text of Item 5.07 of the Original Report, as amended hereby. |